CYTOO has teamed up with Cenix BioScience and three European academic partners to challenge the current limits of high throughput (HT) RNAi screening in cultured cells. The SME-driven project, coordinated by CYTOO, aims to combine HT applications of RNAi with an emerging new technology for normalizing cultured cells' behavior by growing them on adhesive micropatterns. Currently in its first year of development, the consortium is seeking to put together an end user committee, with annual meetings, which would have privileged access to the consortium results, and which would provide precious feedback and contribute to future orientations of the development work.